United States - English - NLM (National Library of Medicine)

clipper distributing company, llc - iron (unii: e1uol152h7) (iron - unii:e1uol152h7) - iron 100 mg in 1 ml

United States - English - NLM (National Library of Medicine)

fresenius medical care holdings, inc. - iron sucrose (unii: fz7nyf5n8l) (ferric cation - unii:91o4lml611) - ferric cation 20 mg in 1 ml - venofer is indicated for the treatment of iron deficiency anemia (ida) in patients with chronic kidney disease (ckd). - known hypersensitivity to venofer risk summary published studies on intravenous iron sucrose treatment after the first trimester of pregnancy have not shown adverse maternal or fetal outcomes (see data) . available reports of intravenous iron sucrose use in pregnant women during the first trimester are insufficient to assess the risk of major birth defects and miscarriage. there are risks to the mother and fetus associated with untreated ida in pregnancy as well as risks to the fetus associated with maternal severe hypersensitivity reactions (see clinical considerations) . animal reproduction studies of iron sucrose administered to rats and rabbits during the period of organogenesis at elemental iron doses equivalent to the maximum recommended human dose based on body surface area revealed no evidence of harm to the fetus (see data). the estimated background risk of major birth defects and

United States - English - NLM (National Library of Medicine)

american regent, inc. - iron sucrose (unii: fz7nyf5n8l) (ferric cation - unii:91o4lml611) - ferric cation 20 mg in 1 ml - venofer is indicated for the treatment of iron deficiency anemia (ida) in patients with chronic kidney disease (ckd). - known hypersensitivity to venofer. risk summary published studies on intravenous iron sucrose treatment after the first trimester of pregnancy have not shown adverse maternal or fetal outcomes (see data) . available reports of intravenous iron sucrose use in pregnant women during the first trimester are insufficient to assess the risk of major birth defects and miscarriage. there are risks to the mother and fetus associated with untreated ida in pregnancy as well as risks to the fetus associated with maternal severe hypersensitivity reactions (see clinical considerations) . animal reproduction studies of iron sucrose administered to rats and rabbits during the period of organogenesis at elemental iron doses equivalent to the maximum recommended human dose based on body surface area revealed no evidence of harm to the fetus (see data). the estimated background risk of major birth defects and

Canada - English - Health Canada

pharmascience inc - iron (iron sucrose) - solution - 20mg - iron (iron sucrose) 20mg - iron preparations

Philippines - English - FDA (Food And Drug Administration)

unilab, inc. - iron , vitamin b complex - syrup (oral drops) - each ml contains: iron, elemental (as ferrous sulfate 74.64 mg) 15 mg; pyridoxine hydrochloride (vitamin b6) 5 mg; thiamine hydrochloride (vitamin b1) 10 mg; cyanocobalamin (vitamin b12) 25 mcg; folic acid 10 mcg

Kenya - English - Pharmacy and Poisons Board

glenmark pharmaceuticals limited glenmark house, hdo-corporate building, wing – a, - elemental iron & folic acid - chewable tablet - iron (iii)-hydroxide to elemental iron100mg &… - antianemic preparations - iron preparations: iron

Philippines - English - FDA (Food And Drug Administration)

vonwelt inc. - iron (as ferrous sulfate) - tablet - 325 mg (equivalent to 65 mg elemental iron)

Philippines - English - FDA (Food And Drug Administration)

vonwelt inc.; distributor: drugmaker's laboratories, inc. - iron (as ferrous sulfate) - tablet - 325 mg (equivalent to 65 mg elemental iron)

Philippines - English - FDA (Food And Drug Administration)

am-europharma corporation - iron - film coated tablet - 325 mg (equivalent 65 mg elemental iron)

Philippines - English - FDA (Food And Drug Administration)

uniqure pharma inc.; distributor: uniqure pharma inc. - iron , folic acid - tablet - 200mg (equi. to 65mg elemental iron) 400mcg